References
- Sweetman SC. Martindale: The complete drug reference. 33rd ed. London, Chicago: Pharmaceutical Press; 2002:74–75.
- Mandal SC, Bhattacharyya M, Ghosal SK. In vitro release and permeation kinetics of pentazocine from matrix-dispersion type transdermal drug delivery system. Drug Dev Ind Pharm 1994;20(11):1933–1941.
- Moffat AC. Clarke’s isolation and identification of drugs. 2nd ed. London: Pharmaceutical Press; 1986;860–861.
- Monkhouse DC, Huq AS. Transdermal drug delivery-problems and promises. Drug Dev Ind Pharm 1988;14:183–203.
- Brown MB, Martin GP, Jones SA, Akomeah FK. Dermal and transdermal drug delivery systems: Current and future prospects. Drug Deliv 2006;13:175–187.
- Kurihara BT, Good WR, Feusullin S, Signor C. Skin compatibility of transdermal drug delivery system. J. Control Release 1991;15:271–278.
- Valenta C, Auner BG. The use of polymers for dermal and transdermal delivery. Eur J Pharm Biopharm 2004;58:279–289.
- Iyer SS, Verma PRP. Controlled transdermal drug delivery of propanolol using HPMC matrices: Design, in vitro and in vivo evaluation. J Pharm Pharmacol 2000;52(2):151–156.
- Verma PRP, Murthy TEGK. Transdermal flurbiprofen delivery using HPMC matrices: Design, in vitro and in vivo evaluation. Drug Dev Ind Pharm 1997;23(7):633–638.
- Man M, Chang C, Lee PH, Broman CT, Cleary GW. New improved paddle method for determining the in vitro drug release profiles of transdermal delivery systems. J Control Release 1993;27(1):59–68.
- Berkowitz B, Way EL. Metabolism and excretion of pentazocine in man. J Clin Pharmacol Ther 1969;10:681–689.
- Lui J, Xiao Y, Allen C. Polymer-drug compatibility: A guide to the development of delivery system for the anticancer agent. J Pharm Sci 2004;93(1):132–143.
- Wartewig S, Neubert RHH. Pharmaceutical application of mid-IR and Raman spectroscopy. Adv Drug Del Rev 2005;57:1144–1170.
- Wilson TD. Pentazocine. In: Florey K, editor. Analytical profiles of drug substances. Vol. 13. London: Pharmaceutical Press Inc; 1984;361–416.
- Varshosaz J, Faghihian H, Rastgoo K. Preparation and characterization of metoprolol controlled-release solid dispersions. Drug Deliv 2006;13:295–302.
- Chandak AR, Verma PRP. Transdermal delivery of methotrexate using mixed grades of eudragit: Physicochemical, in vitro and in vivo evaluation. Clin Res Reg Affairs 2008;25(2):53–72.
- Cilurzo F, Minghetti P, Casiraghi A, Tosi L, Pagani S, Montanari L. Polymethacrylates as crystallization inhibitors in monolayer transdermal patches containing ibuprofen. Eur J Pharm Biopharm 2005;60:61–66.
- Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. Mechanism of solute release from porous hydrophilic polymers. Int J Pharm 1983;15:25–35.
- Costa P, Sousa-Lobo JM. Modeling and comparison of dissolution profiles. Eur J Pharm Sci 2001;13:123–133.
- Perioli L, Ambrogi V, Rubini D, Giovagnoli S, Ricci M, Blasi P, Rossi C. Novel mucoadhesive buccal formulation containing metronidazole for the treatment of periodontal disease. J Control Release 2004;95:521–533.
- Mutalik S, Udupa N. Glibenclamide transdermal patches: Physicochemical, pharmacodynamic, and pharmacokinetic evaluations. J Pharm Sci 2004;93(6):1577–1594.
- Rohr UD, Altenburger R, Kissel T. Pharmacokinetics of the transdermal reservoir membrane system delivering β-estradiol: In vitro/in vivo correlation. Pharm Res 1998;15(6):877–882.